Valneva

Valneva Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Valneva (VLA.PA) as of Nov 3, 2026 is -1.26. In the previous year, Net Debt to Free Cash Flow Ratio was -0.57 — a change of 119.30% (lower).

Net Debt/FCF

-1.26

YoY

119.30%

Last updated:

Net Debt to Free Cash Flow Ratio of Valneva is 2025 -1.26 . Net Debt to Free Cash Flow Ratio of Valneva was 2024 -0.57 . It decreases by 119.30% lower compared to the previous year.

The Valneva Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2018
-1.48 EUR
Jan 1, 2019
-3.88 EUR
Jan 1, 2020
-0.84 EUR
Jan 1, 2021
14.26 EUR
Jan 1, 2022
0.50 EUR
Jan 1, 2023
-0.38 EUR
Jan 1, 2024
-0.57 EUR
Jan 1, 2025
-1.26 EUR
The Valneva Net Debt/FCF history
YEARNet Debt/FCFYoY
-1.26+119.30%
-0.57+50.60%
-0.38-176.42%
0.50-96.50%
14.26-1,804.33%
-0.84-78.44%
-3.88+161.54%
-1.48-134.36%
4.32-74.20%
16.73-848.05%
-2.24-5.62%
-2.37—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Net Debt to Free Cash Flow Ratio of Valneva is -1.26 in 2025.

Net Debt to Free Cash Flow Ratio of Valneva changed from -0.57 to -1.26, representing a 119.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Valneva since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Valneva with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Valneva

All Key Metrics — Valneva